Loading
Curadel Surgical Innovations
Curadel Surgical Innovations holds European orphan status for CPI-008 (cRGD-ZW800-1), a dye that makes tumour tissue glow under near-infrared light during surgery, for head and neck cancer.
Also called: Curadel Surgical Innovations B.V.Curadel Surgical Innovations, Inc.Curadel PharmaCuradel
Overview
On 22 June 2026 the EMA granted orphan designation EU/3/26/3253 to cyclo(arginyl-glycyl-aspartyl-D-tyrosyl-lysyl)-nizaracianine-1, published as cRGD-ZW800-1, for the treatment of head and neck cancer, sponsored by Curadel Surgical Innovations B.V. (B.V. is the Dutch private-company form). Investigator-led phase 2 trials of the agent are registered at Erasmus Medical Center in oral cancer (NCT04191460) and in laryngeal and hypopharyngeal cancer (NCT05752149).
Headquarters
Not confirmed, NL
Scorecard
All companies#617of 1706 companies, score 5
- phase 1/2 +1
- modalities +2
- 24-month regulatory events +2
0 approved, 0 in phase 3, 1 earlier, 0 targets, 0 registry studies. Formula on the scorecards page.
Type
Stage
Startup
Website
Products
1Phase 2Tumour-targeted near-infrared fluorescence imaging agent
CPI-008 (cRGD-ZW800-1) is an experimental dye that sticks to tumour tissue so surgeons can see it under near-infrared light. It has been tested in phase 2 trials and has European orphan status for head and neck cancer.
Notes
- The company website refused automated reads (403) on 4 November 2026, so nothing it says about the company, its other programmes, funding or headquarters is recorded here; the record rests on the EMA designation and the trial registry.
Connected
5Similar pages
- CompanyFluoGuide
Shares Fluorescence-guided surgery, Head and neck squamous cell carcinoma.
- IdeaReal-time margin assessment and image-guided surgery as the global standard
Shares Fluorescence-guided surgery, Head and neck squamous cell carcinoma.
- InstitutionChao Family Comprehensive Cancer Center, UC Irvine
Shares Fluorescence-guided surgery, Head and neck squamous cell carcinoma.
- IdeaA pragmatic trial network for intraoperative margin tools, paid on margin reduction
Shares Fluorescence-guided surgery, Head and neck squamous cell carcinoma.
- InstitutionChang Gung Memorial Hospital
Shares Fluorescence-guided surgery, Head and neck squamous cell carcinoma.
- TechnologySurgical robots: da Vinci, Hugo, Versius and single-port systems
Shares Fluorescence-guided surgery, Head and neck squamous cell carcinoma.
- PathwayInvasion: proteases, adhesion & the invasive front
Shares Fluorescence-guided surgery, Head and neck squamous cell carcinoma.
cancers
fronts
technologies
Imaging agents
Phase 2Tumour-targeted near-infrared fluorescence imaging agent
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
curadelpharma.com · 1
European Medicines Agency · 1
A source that has moved or gone is reported by the weekly link check. /audit/